Want to see TSE:OPTI full AI Analyst Report?
OPTI Stock Chart & Stats
C$6.83
C$0.09(1.35%)
At close: 4:00 PM EDT
C$6.83
C$0.09(1.35%)
Day’s Range― - ―
52-Week RangeC$5.65 - C$12.60
Previous CloseN/A
Volume8.12K
Average Volume (3M)4.83K
Market Cap
C$38.02M
Enterprise ValueC$23.87
Total Cash (Recent Filing)C$13.07M
Total Debt (Recent Filing)C$5.14M
Price to Earnings (P/E)―
Beta0.55
Next Earnings
Feb 02, 2027EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.95
Shares Outstanding5,725,867
10 Day Avg. Volume3,467
30 Day Avg. Volume4,830
Financial Highlights & Ratios
PEG Ratio0.24
Price to Book (P/B)5.70
Price to Sales (P/S)87.81
P/FCF Ratio-13.78
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Diversified Mushroom PlatformThe company participates across cultivation, processing, and supply rather than relying on one product format. This platform can support functional mushroom, research, and legally permitted psychedelic applications as regulated markets and customer needs develop.
Equity CushionA meaningful equity base provides some protection against balance-sheet stress and gives management more flexibility than an asset base funded predominantly by debt. This cushion may help sustain operations while the company works toward commercial scale.
Funding FlexibilityAccess to a sizable equity facility could extend the company’s operating runway and support production or market expansion without relying solely on near-term product revenue. Its usefulness is tempered by potential dilution and convertible-note terms.
Bears Say
Persistent UnprofitabilityDeeply negative gross and operating margins indicate that current production and sales do not yet cover the cost of generating revenue. Persistent losses reduce internally generated capital and make the path to self-sustaining growth dependent on operational improvement.
Sustained Cash BurnOperating and free cash flow remain materially negative, showing that reported losses are translating into actual cash outflows. Continued burn can consume available funding and increase reliance on equity issuance or other financing before the business reaches cash-flow breakeven.
Low And Declining Revenue ScaleVery low revenue and a recent year-over-year decline suggest limited commercial scale and weak current demand conversion. This constrains fixed-cost absorption, reduces operating leverage, and leaves the company vulnerable if new customers or regulated-market opportunities take longer to develop.
Optimi Health News
OPTI FAQ
What was Optimi Health’s price range in the past 12 months?
Optimi Health lowest stock price was C$5.65 and its highest was C$12.60 in the past 12 months.
What is Optimi Health’s market cap?
Optimi Health’s market cap is C$38.02M.
When is Optimi Health’s upcoming earnings report date?
Optimi Health’s upcoming earnings report date is Feb 02, 2027 which is in 150 days.
How were Optimi Health’s earnings last quarter?
Optimi Health released its earnings results on Aug 14, 2026. The company reported -C$0.56 earnings per share for the quarter, missing the consensus estimate of -C$0.4 by -C$0.16.
Is Optimi Health overvalued?
According to Wall Street analysts Optimi Health’s price is currently Overvalued.
Does Optimi Health pay dividends?
Optimi Health does not currently pay dividends.
What is Optimi Health’s EPS estimate?
Optimi Health’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Optimi Health have?
Optimi Health has 5,725,867 shares outstanding.
What happened to Optimi Health’s price movement after its last earnings report?
Optimi Health reported an EPS of -C$0.56 in its last earnings report, missing expectations of -C$0.4. Following the earnings report the stock price went down -0.752%.
Which hedge fund is a major shareholder of Optimi Health?
Currently, no hedge funds are holding shares in TSE:OPTI
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Optimi Health Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
2.79%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
82.95%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Optimi Health
Optimi Health Corp. focuses on developing an integrated brand of functional mushrooms specifically for the Canadian health and wellness food markets. The company manages the entire process from the cultivation and extraction to the processing and distribution of these mushroom strains. Among the fungi varieties it offers are Lions Mane, Reishi, Turkey Tail, Chaga, and Cordyceps. Incorporated in 2020, the company was initially known as 1251418 BC Ltd. before officially changing its name to Optimi Health Corp. in August of that year. Its operations are headquartered in Vancouver, Canada.
Technical Analysis
Rapid Dose Therapeutics Corp
―
MediPharm Labs
―
PharmaCielo
―
Rubicon Organics
―
Avicanna
―